Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026)

Bausch Health Companies' (BHC) quarterly Non-Current Deferred Tax Liability came in at $179.0 million in Q1 2026, up 33.58% year-on-year from $134.0 million in Q1 2025, and up 21.77% quarter-over-quarter from $147.0 million in Q4 2025.

Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Non-Current Deferred Tax Liability across 17 years of filings, most recently posting $179.0 million for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $179.0 million, up 33.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $179.0 million (up 33.58% YoY), and the FY2025 annual result was $147.0 million, up 14.84% from the prior year.
  • Non-Current Deferred Tax Liability came in at $179.0 million for Q1 2026 at Bausch Health Companies, up from $147.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $552.0 million in Q1 2022 to a low of $128.0 million in Q4 2024.
  • The 5-year median for Non-Current Deferred Tax Liability is $179.0 million (2026), against an average of $253.8 million.
  • Across the five-year window, Non-Current Deferred Tax Liability tumbled 66.84% in 2024 and soared 33.58% in 2026, its largest moves.
  • Bausch Health Companies' Non-Current Deferred Tax Liability stood at $390.0 million in 2022, then decreased by 1.03% to $386.0 million in 2023, then plunged by 66.84% to $128.0 million in 2024, then rose by 14.84% to $147.0 million in 2025, then grew by 21.77% to $179.0 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $179.0 million (Q1 2026), $147.0 million (Q4 2025), and $145.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 179.00 Mn
Mar 31, 2026 179.00 Mn
Dec 31, 2025 147.00 Mn
Dec 31, 2025 147.00 Mn
Sep 30, 2025 145.00 Mn
Sep 30, 2025 145.00 Mn
Jun 30, 2025 144.00 Mn
Jun 30, 2025 144.00 Mn
Mar 31, 2025 134.00 Mn
Mar 31, 2025 134.00 Mn
Dec 31, 2024 128.00 Mn
Dec 31, 2024 128.00 Mn
Sep 30, 2024 169.00 Mn
Sep 30, 2024 169.00 Mn
Jun 30, 2024 170.00 Mn
Jun 30, 2024 170.00 Mn
Mar 31, 2024 170.00 Mn
Mar 31, 2024 170.00 Mn
Dec 31, 2023 386.00 Mn
Dec 31, 2023 386.00 Mn